Mitral Valve Disease
The study is a multi-center, prospective, single-arm, and non-randomized study designed to evaluate the safety and function of the Edwards Lifesciences Cardi-AQ-Edwards™ Transcatheter Mitral Valve with the Transseptal Delivery System.
Principal Investigator: Robert L. Smith, II, MD
Locations: Baylor Scott & White The Heart Hospital – Plano
Sponsor: Edwards Lifesciences
IRB Number: 014-278
Trial Status: Enrolling
Exclusions: Adults only
Change in Care: Participating may change your care
Brittany Zingler, RN469.814.4737Brittany.Zingler@BSWHealth.org
Necole Kell, RN469.814.4871Necole.Kell@BSWHealth.org
Early Feasibility Study of the CardiAQ™ Transcatheter Mitral Valve Implantation (TMVI) System For Treatment of Moderate to Severe Mitral Regurgitation
Get Detailed Information On Clinicaltrials.gov »
Physicians are members of the medical staff at one of Baylor Health Care System's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Health Care System.